Loading clinical trials...

Structural Imaging Assisted Retinal Fluorescence Lifetime Imager (STARFLI) | Clinical Trials | Clareo Health

UNKNOWN

Structural Imaging Assisted Retinal Fluorescence Lifetime Imager (STARFLI)

Structural Imaging Assisted Retinal Fluorescence Lifetime Imager (STARFLI) Using a High-speed Fluorescence Lifetime Measurement Scheme

NCT05819307•Insel Gruppe AG, University Hospital Bern

View on ClinicalTrials.gov

Summary

To investigate the feasibility of a combined OCT/FLIM device

Detailed Description

To investigate the feasibility of a combined Optical coherence tomography/ Fluorescence Lifetime Measurement (OCT/FLIM) device.

Eligibility

Age

18 - 120 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Subject must be willing to give written informed consent
•Age: Patients and Probands 18 years or greater
•Both eyes will be assessed in the study

Exclusion Criteria

•Patients not willing or able to sign informed consent
•Patients younger than 18 years
•Patients with epilepsy

Locations (1)

Department of Ophthalmology, Bern University Hospital, Bern, 3010 Bern, Switzerland

Bern, Switzerland

Key Dates

Start Date

May 1, 2023

Primary Completion Date

December 31, 2023

Completion Date

May 1, 2024

Last Updated

April 19, 2023

Enrollment

ESTIMATED participants

Conditions

Retinal Disease

Interventions

OCT/FLIM

DEVICE

Contacts

Pia Steinger

CONTACT

+41316328546 pia.steinger@insel.ch

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

NCT06789445

Primary Photoreceptor DiseaseRetinitis Pigmentosa (RP)+7 more

View study

RECRUITINGNA

COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease

NCT06380075

Retinal Disease

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 19, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Structural Imaging Assisted Retinal Fluorescence Lifetime Imager (STARFLI)

Inclusion Criteria

Exclusion Criteria

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease

Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries

Metabolomic Profile of Vitreoretinal Diseases: an NMR-Based Approach Using Vitreous.

Epidemiologic Assessment of Diabetic Retinopathy in Egypt Using Ultrawide Field Fundus Photographs

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study